NANCY H AGEE, a director at $PGEN, bought 10,645 shares of the company on 08-28-2025 for an estimated $49,490. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 5.5%. Following this trade, they now own 202,841 shares of this class of $PGEN stock.
$PGEN Insider Trading Activity
$PGEN insiders have traded $PGEN stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $PGEN stock by insiders over the last 6 months:
- NANCY H AGEE has made 2 purchases buying 26,005 shares for an estimated $98,642 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PGEN Hedge Fund Activity
We have seen 69 institutional investors add shares of $PGEN stock to their portfolio, and 55 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PARKMAN HEALTHCARE PARTNERS LLC removed 1,648,520 shares (-51.7%) from their portfolio in Q2 2025, for an estimated $2,340,898
- SCHONFELD STRATEGIC ADVISORS LLC removed 1,355,786 shares (-48.5%) from their portfolio in Q2 2025, for an estimated $1,925,216
- PATIENT CAPITAL MANAGEMENT, LLC removed 1,103,560 shares (-6.4%) from their portfolio in Q2 2025, for an estimated $1,567,055
- MORGAN STANLEY added 1,007,864 shares (+97.6%) to their portfolio in Q2 2025, for an estimated $1,431,166
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 975,244 shares (+593.0%) to their portfolio in Q2 2025, for an estimated $1,384,846
- BANK OF AMERICA CORP /DE/ added 599,914 shares (+258.2%) to their portfolio in Q2 2025, for an estimated $851,877
- RENAISSANCE TECHNOLOGIES LLC removed 505,400 shares (-63.7%) from their portfolio in Q2 2025, for an estimated $717,668
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PGEN Analyst Ratings
Wall Street analysts have issued reports on $PGEN in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 08/19/2025
- JMP Securities issued a "Market Outperform" rating on 08/19/2025
- Cantor Fitzgerald issued a "Overweight" rating on 05/15/2025
- Citizens Capital Markets issued a "Market Outperform" rating on 03/20/2025
To track analyst ratings and price targets for $PGEN, check out Quiver Quantitative's $PGEN forecast page.
$PGEN Price Targets
Multiple analysts have issued price targets for $PGEN recently. We have seen 4 analysts offer price targets for $PGEN in the last 6 months, with a median target of $7.0.
Here are some recent targets:
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $8.5 on 08/19/2025
- Jason N. Butler from JMP Securities set a target price of $8.0 on 08/19/2025
- Jason Butler from Citizens Capital Markets set a target price of $6.0 on 03/20/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
